Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for BioMed Research International, enter your email address in the box below.

BioMed Research International
Volume 2015 (2015), Article ID 625981, 7 pages
http://dx.doi.org/10.1155/2015/625981
Research Article

Investigation of the Vitamin D Receptor Polymorphisms in Acromegaly Patients

Muzaffer Ilhan,1 Bahar Toptas-Hekimoglu,2 Ilhan Yaylim,2 Seda Turgut,3 Saime Turan,2 Ozcan Karaman,1 and Ertugrul Tasan1

1Department of Endocrinology and Metabolism, Bezmialem University, 34093 Istanbul, Turkey
2Department of Molecular Medicine, The Institute of Experimental Medicine, 34093 Istanbul, Turkey
3Department of Internal Medicine, Bezmialem University, 34093 Istanbul, Turkey

Received 13 October 2014; Revised 15 December 2014; Accepted 15 February 2015

Academic Editor: Dharambir K. Sanghera

Copyright © 2015 Muzaffer Ilhan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. M. Holdaway and C. Rajasoorya, “Epidemiology of acromegaly,” Pituitary, vol. 2, no. 1, pp. 29–41, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Melmed, “Acromegaly pathogenesis and treatment,” The Journal of Clinical Investigation, vol. 119, no. 11, pp. 3189–3202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Beckers and A. F. Daly, “The clinical, pathological, and genetic features of familial isolated pituitary adenomas,” European Journal of Endocrinology, vol. 157, no. 4, pp. 371–382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Vallar, A. Spada, and G. Giannattasio, “Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas,” Nature, vol. 330, no. 6148, pp. 566–568, 1987. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Pei and S. Melmed, “Isolation and characterization of a pituitary tumor-transforming gene (PTTG),” Molecular Endocrinology, vol. 11, no. 4, pp. 433–441, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Bertherat, P. Chanson, and M. Montminy, “The cyclic adenosine 3′,5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas,” Molecular Endocrinology, vol. 9, no. 7, pp. 777–783, 1995. View at Google Scholar · View at Scopus
  7. E. Giovannucci, “The epidemiology of vitamin D and cancer incidence and mortality: a review (United States),” Cancer Causes & Control, vol. 16, no. 2, pp. 83–95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Liu, M.-H. Lee, M. Cohen, M. Bommakanti, and L. P. Freedman, “Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937,” Genes & Development, vol. 10, no. 2, pp. 142–153, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Labuda, T. M. Fujiwara, M. V. Ross et al., “Two hereditary defects related to vitamin D metabolism map to the same region of human chromosome 12q13-14,” Journal of Bone and Mineral Research, vol. 7, no. 12, pp. 1447–1453, 1992. View at Google Scholar · View at Scopus
  10. M. R. Haussler, C. A. Haussler, P. W. Jurutka et al., “The vitamin D hormone and its nuclear receptor: molecular actions and disease states,” The Journal of Endocrinology, vol. 154, pp. S57–S73, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Guibourdenche, C. Djakoure, D. Porquet et al., “Retinoic acid stimulates growth hormone synthesis in human somatotropic adenoma cells: characterization of its nuclear receptors,” Journal of Cellular Biochemistry, vol. 65, no. 1, pp. 25–31, 1997. View at Publisher · View at Google Scholar
  12. M. L. Slattery, “Vitamin D receptor gene (VDR) associations with cancer,” Nutrition Reviews, vol. 65, supplement 2, pp. S102–S104, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. C. D. Davis, “Vitamin D and cancer: current dilemmas and future research needs,” The American Journal of Clinical Nutrition, vol. 88, no. 2, pp. 565S–569S, 2008. View at Google Scholar · View at Scopus
  14. Q. Chen and A. C. Ross, “Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 40, pp. 14142–14149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Giustina, P. Chanson, M. D. Bronstein et al., “A consensus on criteria for cure of acromegaly,” The Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 7, pp. 3141–3148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, article 1215, 1988. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Yaylim-Eraltan, H. A. Ergen, S. Arikan et al., “Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer,” Cell Biochemistry and Function, vol. 25, no. 6, pp. 731–737, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Carling, P. Ridefelt, P. Hellman, J. Rastad, and G. Åkerström, “Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism,” The Journal of Clinical Endocrinology & Metabolism, vol. 82, no. 6, pp. 1772–1775, 1997. View at Google Scholar · View at Scopus
  19. J. C. Barrett, B. Fry, J. Maller, and M. J. Daly, “Haploview: analysis and visualization of LD and haplotype maps,” Bioinformatics, vol. 21, no. 2, pp. 263–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. R. Haussler, G. K. Whitfield, C. A. Haussler et al., “The nuclear vitamin D receptor: biological and molecular regulatory properties revealed,” Journal of Bone and Mineral Research, vol. 13, no. 3, pp. 325–349, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. A. G. Uitterlinden, Y. Fang, J. B. J. van Meurs, H. A. P. Pols, and J. P. T. M. Van Leeuwen, “Genetics and biology of vitamin D receptor polymorphisms,” Gene, vol. 338, no. 2, pp. 143–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Herman, J. Fagin, R. Gonsky, K. Kovacs, and S. Melmed, “Clonal origin of pituitary adenomas,” The Journal of Clinical Endocrinology and Metabolism, vol. 71, no. 6, pp. 1427–1433, 1990. View at Publisher · View at Google Scholar · View at Scopus
  23. R. J. Frampton, S. A. Omond, and J. A. Eisman, “Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites,” Cancer Research, vol. 43, no. 9, pp. 4443–4447, 1983. View at Google Scholar · View at Scopus
  24. P. Ordonez-Moran, M. J. Larriba, N. Pendas-Franco, O. Aguilera, J. M. Gonzalez-Sancho, and A. Munoz, “Vitamin D and cancer: an update of in vitro and in vivo data,” Frontiers in Bioscience, vol. 10, no. 2, pp. 2723–2749, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Arai, K.-I. Miyamoto, Y. Taketani et al., “A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women,” Journal of Bone and Mineral Research, vol. 12, no. 6, pp. 915–921, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. P. W. Jurutka, L. S. Remus, G. K. Whitfield et al., “The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB,” Molecular Endocrinology, vol. 14, no. 3, pp. 401–420, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Köstner, N. Denzer, C. S. L. Müller, R. Klein, W. Tilgen, and J. Reichrath, “The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature,” Anticancer Research, vol. 29, no. 9, pp. 3511–3536, 2009. View at Google Scholar · View at Scopus
  28. W. Y. Chen, E. R. Bertone-Johnson, D. J. Hunter, W. C. Willett, and S. E. Hankinson, “Associations between polymorphisms in the vitamin D receptor and breast cancer risk,” Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 10, pp. 2335–2339, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. D. Mittal, P. K. Manchanda, S. Bhat, and H. K. Bid, “Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population,” BJU International, vol. 99, no. 4, pp. 933–937, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Lurie, L. R. Wilkens, P. J. Thompson et al., “Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 12, pp. 2566–2571, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. T. Tayeb, C. Clark, N. E. Haites, L. Sharp, G. I. Murray, and H. L. McLeod, “Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia,” Saudi Medical Journal, vol. 25, no. 4, pp. 447–451, 2004. View at Google Scholar · View at Scopus
  32. S. Abbas, A. Nieters, J. Linseisen et al., “Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk,” Breast Cancer Research, vol. 10, no. 2, article R31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Zmuda, J. A. Cauley, and R. E. Ferrell, “Molecular epidemiology of vitamin D receptor gene variants,” Epidemiologic Reviews, vol. 22, no. 2, pp. 203–217, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Fang, J. B. J. van Meurs, A. D'Alesio et al., “Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam study,” The American Journal of Human Genetics, vol. 77, no. 5, pp. 807–823, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. P. W. Jurutka, G. K. Whitfield, J.-C. Hsieh, P. D. Thompson, C. A. Haussler, and M. R. Haussler, “Molecular nature of the vitamin D receptor and its role in regulation of gene expression,” Reviews in Endocrine and Metabolic Disorders, vol. 2, no. 2, pp. 203–216, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Kamenický, A. Blanchard, C. Gauci et al., “Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria?” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 6, pp. 2124–2133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Takamoto, H. Tsuchiya, T. Onishi et al., “Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy,” The Journal of Clinical Endocrinology & Metabolism, vol. 61, no. 1, pp. 7–11, 1985. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Menaa, F. Vrtovsnik, G. Friedlander, M. Corvol, and M. Garabédian, “Insulin-like growth factor I, a unique calcium-dependent stimulator of 1,25-dihydroxyvitamin D3 production: studies in cultured mouse kidney cells,” Journal of Biological Chemistry, vol. 270, no. 43, pp. 25461–25467, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. M. J. E. Wassenaar, N. R. Biermasz, N. A. T. Hamdy et al., “High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly,” European Journal of Endocrinology, vol. 164, no. 4, pp. 475–483, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Dayangac-Erden, A. Karaduman, and H. Erdem-Yurter, “Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients,” Archives of Dermatological Research, vol. 299, no. 10, pp. 487–491, 2007. View at Publisher · View at Google Scholar · View at Scopus